Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Atlas Copco Group has complemented industrial pumps portfolio with external gear pumps manufacturer

Nacka, Sweden, January 03, 2024: KRACHT GmbH (Kracht), a manufacturer of high-quality technologies including external gear pumps, fluid measurement, valves, hydraulic drives, and dosing systems has become part of Atlas Copco Group.Kracht was founded in 1911 and has its headquarters in Werdhol, Germany. The company has subsidiaries in US, China and Hungary, and approximately 440 employees. In 2022, Kracht had revenues of approximately 72 MEUR (766 MSEK*). The purchase price is not disclosed. The acquisition was announced December 4[th] 2023 and is now closed. The business has become part

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseJanuary 3, 2024 at 9.30 am EETRepurchase of Outokumpu’s own shares On January 2, 2024, Outokumpu has completed repurchases of its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |88,162 |4.3517

Faron Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Faron Pharmaceuticals Oy(“Faron” or “Company”)   Faron Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference   Press release   TURKU, FINLAND / BOSTON, MA – January 3, 2024 - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate immunity in hematological and solid tumor microenvironments, today announces that Dr. Markku Jalkanen, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday

Outokumpu increases its ownership in Rajakiiri wind farm in Tornio

Outokumpu OyjPress releaseJanuary 3, 2024 at 9:00 am EETOutokumpu increases its ownership in Rajakiiri wind farm in Tornio   Outokumpu is the global leader in sustainable stainless steel and is continuously looking for ways to further lower climate impact across the value chain. Investments in renewable and CO\2\ free energy production are crucial steps to gradually reduce our indirect emissions and to optimize the power supply to our needs. As part of Outokumpu's strategy to strengthen its leadership in sustainability and increase its self-sufficiency in energy production, Outokumpu

Transaction in Own Shares

    3 January 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |02/01/2024|+------------------------------------------------------------

SRV starts change negotiations

SRV GROUP PLC       STOCK EXCHANGE RELEASE     3 JANUARY 2024       09.00 EET  SRV starts change negotiations  SRV starts change negotiations, the goal of which is to adjust the company’s costs to meet the challenging ongoing market situation. With the help of negotiations, the company aims for cost savings of around 4 million euros for 2024.   ”The volume of housing construction has shrunk to a record low, as both consumer and investor demand have decreased sharply especially with the rise in interest rates. Investor demand is also weak in the business construction, where, however,

Launch of Ovzon 3 targeted for tonight

Ovzon’s revolutionary geostationary communications satellite Ovzon 3 is targeted for launch tonight from Cape Canaveral Space Force Station in Florida. The 10-minute window opens at 6.04 p.m. ET (00:04 Swedish time). If needed, a back-up day is available on January 4 with a launch window opening at at 4:47 p.m. ET (22:47 Swedish time). As always, delays can occur.The launch broadcast will begin at approximately 5 p.m ET today January 3, and will be available on Ovzon's website. The launch will also be available onwww.spacex.com . In addition, Ovzon is organizing a

Zwipe AS – information about the warrants issued in connection with the rights issue

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN ZWIPE AS. SEE ALSO THE SECTION "IMPORTANT INFORMATION" BELOW IN THIS DOCUMENT. OSLO, NORWAY – 3 January 2024 – Reference is made to the stock exchange announcement published by Zwipe AS (the "Company") on 14 December 2023

Ways to Refresh Your Home For The New Year

The new year is the perfect time to make some changes to your home. As you take down your Christmas decorations and put the previous year behind you, it’s a great time to start thinking of ways to update your home for the upcoming year. Plus, once your decorations have been put away, your home may look quite bare, opening up the opportunity for inspiring new home ideas.   [A room with a door and a wood floor Description automatically generated]   Interior designer Ryan McDonough at MyJobQuote.co.uk  has teamed up with a range of other interior

Nordea Bank Abp: Repurchase of own shares on 02.01.2024

Nordea Bank AbpStock exchange release – Changes in company’s own shares02.01.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 02.01.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |47,547 |11.36 |540,295.58

Notice of extraordinary general meeting in Speqta AB (publ)

The shareholders of Speqta AB (publ), reg. no. 556710-8757 (the "Company"), are hereby invited to the Extraordinary General Meeting on Friday 2 February 2024 at 10:00 a.m. at Setterwalls Advokatbyrå at Sturegatan 10 in Stockholm. Registration for the meeting begins at 09:45.   Notification of attendance Shareholders who wish to attend the meeting must: •        be registered as a shareholder in the share register kept by Euroclear Sweden AB in respect of the circumstances on Thursday 25 January 2024, and •        not later than Monday 29 January 2024 have notified

Speqta appoints BrightBid's CEO as Group CEO

  Speqta AB's (publ) ("Speqta") board of directors has today decided to appoint BrightBid's CEO Gustav Westman as Group CEO of Speqta and he will take up the position on 3 January 2024. Speqta's current CEO Fredrik Lindros, who has carried out the recent years’ transformation of the company, is proposed to join Speqta's board of directors as an ordinary member, by convening an extraordinary general meeting.     In July 2023, Speqta acquired the fast-growing AI company BrightBid. Gustav Westman has successfully built BrightBid from scratch into a SaaS business with strong

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 02 January 2024 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 02 January it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)Number of

Buy-back of shares in Arise during week 52, 2023

During the period between 27 December and 29 December 2023 Arise AB (publ) (LEI code 549300FOT7EE85QYB655) (“Arise”) repurchased, in total, 61,690 own shares (ISIN code SE0002095604) under the share repurchase program initiated by the Board of Directors to deliver shareholder value and to optimize the capital structure of the company. The share buy-backs form a part of the share repurchase program of a maximum amount of SEK 100 million, which Arise announced on 14 November 2023. The share repurchase program, which runs from 16 November 2023 until the date of Arise's Annual General

Fodelia Oyj: Share Repurchase 2.1.2024

Fodelia Oyj Announcement  2.1.2024 Fodelia Oyj: Share Repurchase 2.1.2024 In the Helsinki Stock Exchange Trade date           2.1.2024Bourse trade         BuyShare                  FODELIAAmount             1 500 SharesAverage price/ share    5,6800 EURTotal cost            8 520,00 EUR Fodelia Oyj now holds a total of 15 568 sharesincluding the shares repurchased on 2.1.2024 On behalf of Fodelia Oyj Nordea Bank Oyj Janne Sarvikivi

#24-1 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Lindab triples its sales in the USA with the acquisition of Vicon, leading manufacturer of machines for rectangular ventilation ducts

Lindab acquires Vicon, the leading US manufacturer of rectangular ventilation duct machinery. Lindab is today, through the brands Spiro and Firmac, a leader in machines for the production of ventilation ducts in Europe. The acquisition more than triples Lindab's sales in the US while doubling global sales of machines for duct production.Vicon is a well-known US producer of a wide range of machines for manufacturing of rectangular ventilation ducts. Production takes place in Pevely, MO and in Meadville, PA. The head office is located in Bohemia, NY. Vicon has about 20 distributors across the

Wetteri Plc – Manager’s Transactions – PM Ruukki Oy

Wetteri Plc   Manager’s Transactions   2 January 2024 17.00 EETWetteri Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: PM Ruukki Oy Position: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In Issuer Name: Markku Kankaala Position: Member of the Board Issuer: Wetteri Oyj LEI: 743700TDB62DGAFROB24 Notification type: INITIAL NOTIFICATION Reference number: 28768/5/4 ____________________________________________ Transaction date:

Total Voting Rights

2 January 2024 15:00 GMT Transparency DirectiveVoting rights and capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 December 2023 the issued share capital of AstraZeneca PLC with voting rights is 1,550,162,626 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,550,162,626. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they

OncoZenge submits application for PRIME status in the EU

Stockholm, Sweden, January 2[nd] 2024 – OncoZenge AB (publ), a leading biotechnology company developing BupiZenge™, an innovative, opioid-sparing treatment for oral pain, today confirms the submission of an application for PRIME (Priority Medicines) status with the European Medicines Agency (EMA).The PRIME initiative offers early, proactive, and enhanced support to accelerate the evaluation of promising medicines, to reach patients faster. To be eligible for PRIME, medicines must target an unmet medical need and show potential benefits for patients based on clinical data.  BupiZenge™ is

There are no items matching the current filter
There are no more items matching the current filter
Back to top